Pavmed IPO grosses $5.3m
Updated with the correct stock ticker for currently trading Pavmed units (PAVMU) Pavmed said today that its initial public offering grossed $5.3 million, after extending the flotation last month for an extra 45 days. Pavmed is developing devices in 5 areas, according to its IPO registration: The PortIO long-term implantable vascular access device; the Caldus line disposable tissue ablation devices, including renal denervation for hypertension; the CarpX percutaneous device to treat carpal tunnel syndrome; the NextCath self-anchoring short-term catheter; and the NextFlo disposable infusion pump. The 1.06 million-share offe...
Source: Mass Device - April 28, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Wall Street Beat Pavmed Source Type: news

Health Tip: At Risk for Carpal Tunnel Syndrome?
-- Carpal tunnel syndrome occurs when tissues in the wrist swell and put pressure on nearby nerves, causing pain and discomfort. Here are common risk factors for the condition, courtesy of the American Academy of Orthopedic Surgeons: Heredity,... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - April 21, 2016 Category: Journals (General) Source Type: news

Health Tip: At Risk for Carpal Tunnel Syndrome?
Title: Health Tip: At Risk for Carpal Tunnel Syndrome?Category: Health NewsCreated: 4/21/2016 12:00:00 AMLast Editorial Review: 4/21/2016 12:00:00 AM (Source: MedicineNet Arthritis General)
Source: MedicineNet Arthritis General - April 21, 2016 Category: Rheumatology Source Type: news

A comparison of opioid use between WCB recipients and other Manitobans for knee, shoulder, back and carpal tunnel release procedures - Kraut A, Raymond CB, Ekuma O, Shafer LA.
This study's objectives were to evaluate whether WCB claimants with conditions requiring certain surgical procedures are more likely to be prescribed outpatient opioids than other Manitobans and whether those prescribed opioids are more likel... (Source: SafetyLit)
Source: SafetyLit - April 14, 2016 Category: Global & Universal Tags: Alcohol and Other Drugs Source Type: news

Carpal tunnel syndrome: Guidelines rate evidence for diagnosis, treatment
The American Academy of Orthopaedic Surgeons has adopted clinical practice guidelines that assign evidence-based ratings for common strategies used to diagnose and treat carpal tunnel syndrome... (Source: Clinical Neurology News)
Source: Clinical Neurology News - March 31, 2016 Category: Neurology Source Type: news

Pavmed extends $6m IPO
Pavmed said earlier this week it will extend its heavily reduced $6 million IPO an additional 45 days. The IPO was dramatically reduced in January, with the company announcing that it planned to float a reduced 1.2 million shares at $5 a piece. Pavmed expects the IPO to bring in $5.4 million after sales commissions but before expenses. The offering includes an 800,000-share over-allotment option, the company said. That’s a far cry from the $23 million top end Pavmed listed when it registered the IPO last May. Pavmed is developing devices in 5 areas, according to its IPO registration: The PortIO long-term implantable...
Source: Mass Device - March 18, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Pavmed Source Type: news

Carpal Tunnel Syndrome Guidelines Published (FREE)
By Kelly Young Edited by André Sofair, MD, MPH, and William E. Chavey, MD, MS The American Academy of Orthopaedic Surgeons has issued new guidelines on managing carpal tunnel syndrome. To diagnose carpal … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - March 4, 2016 Category: Primary Care Source Type: news

Carpal tunnel syndrome
Medical and surgical treatment options in carpal tunnel syndrome and an overview of prognosis. (Source: GP Online Education)
Source: GP Online Education - February 25, 2016 Category: Primary Care Tags: 15.9 Rheumatology, Musculoskeletal and Trauma Source Type: news

MassDevice.com +3 | The top 3 medtech stories for January 25, 2016
Say hello to MassDevice +3, a bite-sized view of the top three medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 3 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.   3. Pavmed scales back IPO to $6m Pavmed dramatically trimmed its pending initial public offering, saying it plans to float 1.2 million shares at $5 apiece for gross proceeds of $6 million. That’s a far cry from the $23 million top end Pavmed listed when it registered the IPO last May. Pavme...
Source: Mass Device - January 25, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 3 Source Type: news

Pavmed scales back IPO to $6m
Pavmed last week dramatically trimmed its pending initial public offering, saying it plans to float 1.2 million shares at $5 apiece for gross proceeds of $6 million. That’s a far cry from the $23 million top end Pavmed listed when it registered the IPO last May. Pavmed is developing devices in 5 areas, according to its IPO registration: The PortIO long-term implantable vascular access device; the Caldus line disposable tissue ablation devices, including renal denervation for hypertension; the CarpX percutaneous device to treat carpal tunnel syndrome; the NextCath self-anchoring short-term catheter; and the NextFlo d...
Source: Mass Device - January 25, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Funding Roundup Initial Public Offering (IPO) Wall Street Beat Cruzar Medsystems Kaleidoscope Medical Pavilion Medical Innovations Pavmed Saphena Medical Vortex Medical Source Type: news

Shell shocked after complex atypical hyperplasia diagnosis – Liz ’ s story
Sorry that this story of mine is so long but so much has happened all interlinked with each other I felt it is all important and might be useful to someone else in similar circumstances. At the beginning of this year after 3 years of no periods I had a couple of small bleeds lasting at most 2 days, shortly after I had an acute chest infection requiring large doses of antibiotics. At a follow up visit re this at my GP surgery I asked if I would be able to have the steroid injection in my thumb which had been cancelled due to the infection, but he felt that I wasn’t totally clear, I’m a bit of a joker and said &#...
Source: The Hysterectomy Association - December 2, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health complex hyperplasia hysterectomy stories Source Type: news

Shell shocked after complex atypical hyperplasia diagnosis – Liz ’ s story
Sorry that this story of mine is so long but so much has happened all interlinked with each other I felt it is all important and might be useful to someone else in similar circumstances. At the beginning of this year after 3 years of no periods I had a couple of small bleeds lasting at most 2 days, shortly after I had an acute chest infection requiring large doses of antibiotics. At a follow up visit re this at my GP surgery I asked if I would be able to have the steroid injection in my thumb which had been cancelled due to the infection, but he felt that I wasn’t totally clear, I’m a bit of a joker and said &#...
Source: The Hysterectomy Association - December 2, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health complex hyperplasia hysterectomy stories Source Type: news

Shell shocked after complex atypical hyperplasia diagnosis – Liz ’ s story
Sorry that this story of mine is so long but so much has happened all interlinked with each other I felt it is all important and might be useful to someone else in similar circumstances. At the beginning of this year after 3 years of no periods I had a couple of small bleeds lasting at most 2 days, shortly after I had an acute chest infection requiring large doses of antibiotics. At a follow up visit re this at my GP surgery I asked if I would be able to have the steroid injection in my thumb which had been cancelled due to the infection, but he felt that I wasn’t totally clear, I’m a bit of a joker and said &#...
Source: The Hysterectomy Association - December 2, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Health complex hyperplasia hysterectomy stories Source Type: news

Shell shocked after complex atypical hyperplasia diagnosis – Liz’s story
The post Shell shocked after complex atypical hyperplasia diagnosis – Liz’s story appeared first on Hysterectomy Association. Sorry that this story of mine is so long but so much has happened all interlinked with each other I felt it is all important and might be useful to someone else in similar circumstances. At the beginning of this year after 3 years of no periods I had a couple of small bleeds lasting at most 2 days, shortly after I had an acute chest infection requiring large doses of antibiotics. At a follow up visit re this at my GP surgery I asked if I would be able to have the steroid injection in my ...
Source: The Hysterectomy Association - December 2, 2015 Category: OBGYN Authors: Linda Parkinson-Hardman Tags: Your Stories Complex Atypical Hyperplasia Source Type: news